Alkeon Capital Management LLC Magenta Therapeutics, Inc. Transaction History

Alkeon Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$6.52 - $8.94 $3.91 Million - $5.36 Million	-600,000 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$9.07 - $15.84 $907,000 - $1.58 Million	100,000 Added 20.0%	600,000 $9.1 Million
Q3 2019 Nov 14, 2019	BUY	$9.63 - $14.0 $963,000 - $1.4 Million	100,000 Added 25.0%	500,000 $5.13 Million
Q2 2019 Aug 14, 2019	BUY	$13.4 - $17.67 $5.36 Million - $7.07 Million	400,000 New	400,000 $5.9 Million
Q3 2018 Nov 14, 2018	SELL	$11.32 - $15.7 $769,760 - $1.07 Million	-68,000 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$13.5 - $14.52 $918,000 - $987,360	68,000 New	68,000 $918,000

442K

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

Get notified when there are updates to the investment portfolio of Alkeon Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alkeon Capital Management LLC with notifications on news.